Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02091999
Title A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications

lung non-small cell carcinoma

peritoneal carcinoma

urethra transitional cell carcinoma

fallopian tube cancer

ovary epithelial cancer

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Therapies

Enfortumab vedotin-ejfv

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Site US00012 Los Angeles California 90033 United States Details
Site US00019 Stanford California 94305 United States Details
Site US00017 Aurora Colorado 80045 United States Details
Site US00006 New Haven Connecticut 06520 United States Details
Site US00007 Miami Florida 33136 United States Details
Site US00008 Tampa Florida 33612 United States Details
Site US00004 Fairway Kansas 66205 United States Details
Site US00005 Ann Arbor Michigan 48109 United States Details
Site US00003 Detroit Michigan 48201 United States Details
Site US00021 Las Vegas Nevada 89119 United States Details
Site US00018 New York New York 10029 United States Details
Site US00002 New York New York 10065 United States Details
Site US00023 Chapel Hill North Carolina 27599 United States Details
Site US00013 Philadelphia Pennsylvania 19111 United States Details
Site US00020 Pittsburgh Pennsylvania 15232 United States Details
Site US00024 Fairfax Virginia 22031 United States Details
Site US00009 Madison Wisconsin 53792 United States Details
Site US00015 Milwaukee Wisconsin 53226 United States Details
Site CA00011 Calgary Alberta T2N 4N2 Canada Details
Site CA00001 Edmonton Alberta T6G 1Z2 Canada Details
Site CA00010 Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field